NCT06250699 A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery
| NCT ID | NCT06250699 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhe Meng |
| Condition | Nonfunctional Adrenal Cortex Adenoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-01-03 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-01-03 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to exploring the role of tubeless after adrenalectomy surgery. The main questions it aims to answer are: 1. The safety of tubeless laparoscopic adrenalectomy； 2. The role of tubeless therapy in rapid recovery after adrenalectomy surgery Participants will be randomly divided into two groups: the non drainage group and the drainage group after laparoscopic adrenal surgery, and their pain, first time out of bed, and intestinal recovery time will be observed.
Eligibility Criteria
Inclusion Criteria: 1. According to the 2022 edition of the Chinese Guidelines for Diagnosis and Treatment of Urological Diseases, patients who meet the surgical indications 2. The patient has signed an informed consent form before joining the clinical trial, and the age at the time of signing the informed consent form is 18-70 years old. Exclusion Criteria: 1. Patients with complications that seriously affect treatment or quality of life 2. The patient has any physical condition that the researcher believes will affect the clinical status 3. Patients who have placed vascular stents such as heart and cerebrovascular stents within the past year 4. Pregnant or lactating patients
Contact & Investigator
meng zhe
PRINCIPAL INVESTIGATOR
Wuhan University
Frequently Asked Questions
Who can join the NCT06250699 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Nonfunctional Adrenal Cortex Adenoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06250699 currently recruiting?
Yes, NCT06250699 is actively recruiting participants. Contact the research team at mengzhe@whu.edu.cn for enrollment information.
Where is the NCT06250699 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT06250699 clinical trial?
NCT06250699 is sponsored by Zhe Meng. The principal investigator is meng zhe at Wuhan University. The trial plans to enroll 200 participants.